Skip to main content
logo
Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
633.71
+5.56 (0.89%)
At close: Aug 26, 2026, 4:00 PM EDT
634.06
+0.35 (0.06%)
After-hours: Aug 26, 2026, 7:56 PM EDT

Thermo Fisher Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21
Revenue
46,33645,19744,55643,73643,21242,89842,87942,37042,34642,49242,85743,42143,52443,80744,91544,16742,82041,12339,21139,059
Revenue Growth
7.23%5.36%3.91%3.22%2.04%0.95%0.05%-2.42%-2.71%-3.00%-4.58%-1.69%1.64%6.53%14.55%13.08%11.95%14.57%21.70%37.06%
Gross Profit
18,99218,50018,30218,10117,84817,77517,74917,32017,31017,23417,10017,38617,35817,68818,97119,61119,96019,88519,63819,952
Operating Income
8,7978,4878,3588,1867,9507,8427,7277,4567,5247,4777,3227,5217,2727,4548,5609,2829,87410,11510,37210,703
Net Income
6,9676,8486,7046,5706,5846,5146,3356,1356,2206,0345,9955,9415,7216,0246,9507,0327,4397,6037,7258,565
Earnings Per Share
18.5818.1917.7417.3217.3017.0616.5315.9516.1315.5915.4515.2614.6415.3417.6317.7918.7919.1919.4621.54
EPS Growth
7.45%6.67%7.32%8.54%7.24%9.37%6.99%4.56%10.18%1.64%-12.37%-14.23%-22.09%-20.03%-9.40%-17.43%-12.99%-3.46%21.93%76.67%

Revenue by Segment
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21
Life Sciences Solutions
10,98510,66910,37410,0329,8319,6879,6319,4969,5429,6509,97710,55411,08311,91213,53114,63515,39415,65915,63115,849
Analytical Instruments
7,6717,5527,5547,5257,4407,4947,4637,3147,2607,2277,2637,1046,9716,8296,6246,4716,3266,2006,0695,980
Specialty Diagnostics
4,7414,6704,6764,6134,5684,5514,5124,4604,4144,4064,4054,4154,3974,3894,7635,0955,3925,5265,6596,179
Laboratory Products and Biopharma Services
25,07824,38023,98423,54123,31123,07423,15722,94022,92823,00123,04123,26923,12622,83222,51120,75918,66116,70714,86214,283
Revenue (Total)
46,33645,19744,55643,73643,21242,89842,87942,37042,34642,49242,85743,42143,52443,80744,91544,16742,82041,12339,21139,059

Cash & Debt
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21
Cash & Investments
4,0643,25610,1053,5466,3905,9475,5706,6458,8237,2508,0806,1513,1333,4828,5242,9191,8882,7524,47712,027
Total Debt
42,54943,16140,85535,68035,22934,25932,77535,51335,42735,66436,71135,43634,02335,33636,15829,16030,26033,25536,33921,711
Net Cash (Debt)
-38,485-39,905-30,750-32,134-28,839-28,312-27,205-28,868-26,604-28,414-28,631-29,285-30,890-31,854-27,634-26,241-28,372-30,503-31,862-9,684
Net Cash Growth
--------------------
Net Cash Per Share
-102.63-105.99-81.35-84.73-75.79-74.16-71.03-75.13-69.01-73.42-73.79-75.33-79.00-81.21-70.14-66.35-71.74-76.93-80.26-24.36

Cash Flow & CapEx
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21
Operating Cash Flow
9,0138,2877,8187,6517,5788,1398,6679,1009,3488,9288,4068,1707,6937,6819,1548,1248,8379,5369,31210,194
Capital Expenditures
-1,695-1,539-1,525-1,540-1,408-1,415-1,400-1,325-1,385-1,368-1,479-1,624-1,839-2,061-2,243-2,524-2,501-2,535-2,523-2,278
Free Cash Flow
7,3186,7486,2936,1116,1706,7247,2677,7757,9637,5606,9276,5465,8545,6206,9115,6006,3367,0016,7897,916
Free Cash Flow Growth
18.61%0.36%-13.40%-21.40%-22.52%-11.06%4.91%18.77%36.03%34.52%0.23%16.89%-7.61%-19.73%1.80%-29.26%-22.09%-13.16%-0.38%39.22%

Margins
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21
Gross Margin
40.99%40.93%41.08%41.39%41.30%41.44%41.39%40.88%40.88%40.56%39.90%40.04%39.88%40.38%42.24%44.40%46.61%48.35%50.08%51.08%
Operating Margin
18.98%18.78%18.76%18.72%18.40%18.28%18.02%17.60%17.77%17.60%17.09%17.32%16.71%17.02%19.06%21.02%23.06%24.60%26.45%27.40%
Pretax Margin
16.37%16.35%16.31%16.28%16.25%16.29%16.31%15.95%16.01%15.33%14.56%14.39%13.85%14.79%17.06%17.61%19.67%20.93%22.54%25.27%
Profit Margin
15.04%15.15%15.05%15.02%15.24%15.19%14.77%14.48%14.69%14.20%13.99%13.68%13.14%13.75%15.47%15.92%17.37%18.49%19.70%21.93%
FCF Margin
15.79%14.93%14.12%13.97%14.28%15.67%16.95%18.35%18.80%17.79%16.16%15.08%13.45%12.83%15.39%12.68%14.80%17.03%17.31%20.27%

Dividends
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21
Dividend Per Share
1.8001.7601.7201.6801.6401.6001.5601.5201.4801.4401.4001.3501.3001.2501.2001.1601.1201.0801.0401.000
Dividend Per Share Growth
9.76%10.00%10.26%10.53%10.81%11.11%11.43%12.59%13.85%15.20%16.67%16.38%16.07%15.74%15.38%16.00%16.67%17.39%18.18%17.65%
Dividend Yield
0.35%0.37%0.30%0.36%0.40%0.32%0.30%0.25%0.27%0.25%0.27%0.27%0.25%0.22%0.22%0.23%0.21%0.18%0.16%0.18%

Valuation
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21
PE Ratio
27.3725.6832.4726.6823.4128.9731.4138.2633.9436.7334.2133.3335.1836.8831.2228.2628.8530.4834.0426.31
Forward PE
20.2219.2224.0519.8117.9221.4122.8727.3124.8226.9324.6521.3921.2524.2725.0022.6625.0226.2932.5529.37
P/FCF Ratio
26.0526.0634.6028.6924.9828.0627.3830.1926.5129.3229.6130.2534.3839.5331.4035.4833.8733.1038.7328.46
PS Ratio
4.123.894.894.013.574.404.645.544.995.224.794.564.625.074.834.505.015.646.715.77